The 20 Best Optic Nerve Atrophy Doctors Near Me in Lutherville Timonium, MD

Andrew R. Carey, MD is a the Neil R. Miller Rising Professor of Ophthalmology in the division of Neuro-Ophthalmology at the Wilmer Eye Institute. He specializes in neuro-ophthalmic disorders such as optic neuritis, uveitis related papillitis, ischemic & hereditary optic neuropathies as well as diseases of the retina, including age-related macular degeneration, diabetic retinopathy, toxic retinopathies and inherited disorders of the retina such as retinitis pigmentosa. Dr. Carey’s clinical and research interests include comparative effectiveness and cost-benefit of intravitreal medications, long-term outcome of treatments for choroidal neovascularization, novel treatments for papillitis, and the use of novel imaging modalities to better diagnose and understand optic nerve and retinal diseases. Dr. Carey received his bachelor's from Davidson College in mathematics in 2006. In 2010, he received his medical degree from the University of South Florida. He completed his ophthalmology residency as Chief Resident in 2014 at the University of South Florida. He then went on to complete his fellowship in neuro-ophthalmology at Bascom Palmer Eye Institute in 2015 and his fellowship in medical retina at the University of Iowa in 2016. Videos Dr. Andrew R. CareyNeuro-Ophthalmology. Dr. Carey is rated as a Distinguished provider by MediFind in the treatment of Optic Nerve Atrophy. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Papilledema, Increased Intracranial Pressure, Optic Nerve Atrophy, and Optic Neuritis. Dr. Carey is board certified in American Board Of Ophthalmology.

Ashley Behrens, M.D., is the Edward St. John Professor in Ophthalmology and chief of the comprehensive ophthalmology division at the Wilmer Eye Institute, Johns Hopkins Medicine. He specializes in the medical and surgical management of cataracts and corneal diseases, including corneal transplantation techniques for Fuchs’ dystrophy and keratoconus, as well as LASIK, PRK and refractive lens exchange. Dr. Behrens received his medical degree from the Universidad Central de Venezuela in Caracas, and completed his ophthalmology residency and fellowship training at the Francisco Risquez Hospital. He completed additional fellowships at the University of Erlangen-Nuremberg in Germany, where he obtained his German Doctorate with Magna Cum Laude Distinction, and then at the University of Southern California and the University of California, Irvine. Dr. Behrens joined the Wilmer faculty in 2003, and served as executive medical director at the King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Saudi Arabia, from July 2010 through August 2014. Dr. Behrens is rated as an Advanced provider by MediFind in the treatment of Optic Nerve Atrophy. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Interstitial Keratitis, Cataract, Optic Atrophy Type 1, Vitrectomy, and Cataract Removal.

"Dr. Shah is an AUPO-fellowship trained ophthalmologist specializing in diseases of the retina, macula, and vitreous. A Pennsylvania native, Dr. Shah attended college at West Chester University of Pennsylvania. He later earned his medical degree at Drexel University College of Medicine and remained there to pursue his residency in Ophthalmology where he was also honored to serve as Chief Resident. Dr. Shah then pursued his fellowship training in vitreoretinal surgery at the Associated Retina Consultants in Phoenix, Arizona. Dr. Shah has been privileged to author or co-author over 40 book chapters and topics as well as publish scientific articles in peer-reviewed journals. He has been invited to lecture both physicians and students on current clinical issues. As a resident, he received multiple honors including Intern of the Year, Resident of the Year, and the Golden Apple for Teaching by the College of Medicine. He was even bestowed with Hahnemann University Hospital's highest award for training physicians – ""Excellence in Clinical Practice for a Fellow, Resident, or Intern."" Dr. Shah enjoys all aspects of retinal disease, but has particular interests in the management of acute, subacute, and chronic retinal disorders including age-related macular degeneration, diabetic retinopathy, and complex retinal detachments. Dr. Shah is a member of the American Society of Retinal Specialists and the American Academy of Ophthalmology.". Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Optic Nerve Atrophy. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Orbital Cellulitis, Hyphema, Kallikrein Hypertension, and Optic Nerve Atrophy. Dr. Shah is board certified in American Board Of Ophthalmology.

Dr. Becker is a neurologist who earned his Medical Degree from Ruprecht Karls University in Heidelberg, Germany in 2001. From 2001 to 2003, he was a Research Assistant in Neuroscience investigating the role of embryonic stem cells in spinal cord injury repair at Washington University School of Medicine in St. Louis, Missouri. At Vanderbilt University Medical Center in Nashville, Tennessee, he completed his residency in Internal Medicine in 2004 and his residency in Neurology in 2007. From there, he completed a year-long fellowship in Spinal Cord Injury Medicine at the Johns Hopkins School of Medicine in Baltimore, MD. Dr. Becker is rated as an Advanced provider by MediFind in the treatment of Optic Nerve Atrophy. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Paraplegia, Relapsing Multiple Sclerosis (RMS), Multiple Sclerosis (MS), and Cerebellar Multiple System Atrophy. Dr. Becker is board certified in American Board Of Psychiatry And Neurology.

Farhad Naseh is an Ophthalmologist practicing medicine in Gaithersburg, Maryland. Dr. Naseh is rated as a Distinguished provider by MediFind in the treatment of Optic Nerve Atrophy. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Optic Atrophy Type 1, Optic Nerve Atrophy, and Hereditary Keratitis.

Dan Yin is an Ophthalmologist practicing medicine in Rockville, Maryland. She has been practicing medicine for over 17 years. Dr. Yin is rated as a Distinguished provider by MediFind in the treatment of Optic Nerve Atrophy. She is also highly rated in 46 other conditions, according to our data. Her clinical expertise encompasses Interstitial Keratitis, Retinal Vasculopathy with Cerebral Leukodystrophy, Familial Exudative Vitreoretinopathy, and Coats Disease.

Arusha Gupta is an Ophthalmologist practicing medicine in Silver Spring, Maryland. Dr. Gupta is rated as a Distinguished provider by MediFind in the treatment of Optic Nerve Atrophy. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Optic Nerve Atrophy, Optic Atrophy Type 1, Ocular Hypertension (OHT), and Kallikrein Hypertension.

Dr. Angeliki Filippatou specializes in the diagnosis, management and treatment of neuroimmunological disorders with a particular focus on multiple sclerosis (MS). Her research focuses on the development of innovative prognostic and monitoring biomarkers for MS and related neuroimmunological conditions, including the integration of emerging digital health tools into disease tracking. Dr. Filippatou earned her medical degree from the National and Kapodistrian University of Athens, Greece and went on to complete her neurology residency at the Johns Hopkins Hospital. She pursued subspecialty fellowship training in neuroimmunology at Johns Hopkins. Her fellowship training was supported by the National Institutes of Health/ National Institute of Neurological Disorders and Stroke and the National MS Society. Dr. Filippatou is rated as an Advanced provider by MediFind in the treatment of Optic Nerve Atrophy. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Optic Neuritis, Multiple Sclerosis (MS), Neuromyelitis Optica, Transverse Myelitis, and Thrombectomy. Dr. Filippatou is board certified in American Board Of Psychiatry And Neurology.

Neil R. Miller, M.D., is Professor of Ophthalmology, Neurology & Neurosurgery. He specializes in neuro-ophthalmology and orbital disease. Dr. Miller received his M.D. degree from the Johns Hopkins University School of Medicine and completed his residency in ophthalmology at the Wilmer Eye Institute, where he also served as chief resident. He completed a fellowship in neuro-ophthalmology at the University of CA, San Francisco. He has been a member of the Wilmer faculty since 1976. Dr. Miller is rated as an Experienced provider by MediFind in the treatment of Optic Nerve Atrophy. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Increased Intracranial Pressure, Benign Essential Blepharospasm, Papilledema, Vitrectomy, and Cataract Removal. Dr. Miller is board certified in American Board Of Ophthalmology.

Prior to joining VED in December, 2017, Dr. Hammer was with Baltimore Washington Eye Center. Dr. Hammer earned his medical degree from the University of Maryland, School of Medicine followed by an Internship at Eisenhower Army Medical Center in Augusta, Georgia. He then completed his training with a residency in Ophthalmology at the Walter Reed Army Medical Center which serves the greater Washington, DC Metro area. Dr. Hammer served as Chief of Ophthalmology at Ireland Community Hospital in Fort Knox, Kentucky. Dr. Hammer enjoys spending time with his family and is very involved with the community. His commitment and his passion for his work is demonstrated by the loyalty of his patients. Dr. Hammer is rated as an Experienced provider by MediFind in the treatment of Optic Nerve Atrophy. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Dry Eye Syndrome, Subconjunctival Hemorrhage, Allergic Conjunctivitis, Conjunctivitis (Pink Eye), and Cataract Removal. Dr. Hammer is board certified in American Board Of Ophthalmology.

Everardo Hernandez-Quintela, M.D., M.Sc., F.A.C.S. is an accomplished cataract and cornea surgeon at the Wilmer Eye Institute’s locations in Baltimore and Lutherville, Maryland. He specializes in both refractive surgery (LASIK and PRK) and corneal transplant. Dr. Hernández-Quintela is the medical director for Wilmer's Patient Access Center for the Eye (PACE). Prior to joining Johns Hopkins Medicine, Dr. Hernandez Quintela was a professor of ophthalmology at the Universidad Nacional Autónoma de México where he led the course on research methodology in ophthalmology and the advanced course on cornea and refractive surgery. He is the founder of the international chapter of the Association of Research in Vision and Ophthalmology (ARVO) in Mexico, known as Colegio Nacional de Investigación en Ciencias Visuales (MARVO). Dr. Hernández-Quintela is a peer review editorial member of the Journal of the American Academy of Ophthalmology and the International Journal of Ophthalmology among other prestigious journals. He held a clinical academic position as head of cornea and refractive surgery services, and head of research at the Asociación para Evitar la Ceguera en México Hospital in Mexico City, which is one of the largest eye hospitals in Latin America. Dr. Hernández-Quintela began his career at Universidad La Salle and Universidad Nacional Autonoma de Mexico in Mexico City. He performed his residency training at the Asociación para Evitar la Ceguera en México Hospital, in Mexico City, and completed his fellowships at the Massachusetts Eye and Ear Infirmary at Harvard Medical School in the United States with professor Dimitri Azar, and at the Hôtel Dieu Hospital, at Université Paris in France with Professor J.M. Legeais and Prof. Yves Pouliquen.Dr. Hernández-Quintela holds a Master in Science from the Universidad Nacional Autónoma de México, School of Medicine. Dr. Hernandez is rated as an Experienced provider by MediFind in the treatment of Optic Nerve Atrophy. His clinical expertise encompasses Cataract, Optic Nerve Atrophy, Optic Atrophy Type 1, and Blepharitis.

Mona Kaleem, M.D. is an Associate Professor of Ophthalmology at the Wilmer Eye Institute. She is a fellowship trained glaucoma and cataract surgeon in Bethesda, Maryland. She is broadly trained in the medical and surgical care of glaucoma. Her excellence in patient care, teaching, and research activities resulted in her selection to the American Glaucoma Society. She was also selected by her peers as a Baltimore Magazine “Top Doctor” in 2018, 2019 and 2021. In 2020, Dr. Kaleem was honored with the American Academy of Ophthalmology's Achievement Award. Dr. Kaleem was born and raised in Maryland. She earned her Bachelor’s degree in Economics with double minors in Biology and Chemistry at Smith College prior to entering the Howard University College of Medicine. There, she was a Trustee Scholar and awardee of the Malcolm X Scholarship due to her leadership in community service. She completed her medical training at Mercy Medical Center, Howard University Hospital, and the Cleveland Clinic. She has a strong interest in volunteerism and has participated in medical missions globally and in underserved areas within the United States. Dr. Kaleem is also known for her involvement in grass roots legislative efforts that impact the way that ophthalmology care is delivered and received in the United States. She is one of the hosts of the Diagnosis Glaucoma podcast and co-authored the book Glaucoma: What Every Patient Should Know with Dr. Harry Quigley. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Kaleem-cv.pdf. Dr. Kaleem is rated as an Experienced provider by MediFind in the treatment of Optic Nerve Atrophy. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Cataract, Vitrectomy, and Trabeculectomy. Dr. Kaleem is board certified in American Board Of Ophthalmology.

Dr. Cremers anchors the Visionary Eye Doctor team and is a widely respected and experienced researcher and clinician in dry eye disease, having spent a decade at Harvard Medical School and the Massachusetts Eye and Ear infirmary. She is a fellow with the American College of Surgeons, specializing in cataract and pterygium surgery. CV https://www.hopkinsmedicine.org/suburban_hospital/_documents/physician%20CV/cremers-cv.pdf. Dr. Cremers is rated as an Experienced provider by MediFind in the treatment of Optic Nerve Atrophy. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Pterygium, Dry Eye Syndrome, Blepharitis, and Glaucoma. Dr. Cremers is board certified in American Board Of Ophthalmology.

Dr. Mowry became interested in multiple sclerosis (MS) prior to beginning college and first performed MS research as an undergraduate biology major at Georgetown University. As a neurology resident at the University of Pennsylvania, she began her multiple sclerosis clinical research activities in conducting a study of visual dysfunction and quality of life in multiple sclerosis. During her fellowship at UCSF, Dr. Mowry evaluated prognostic factors in multiple sclerosis and examined health-related quality of life in multiple sclerosis, particularly as a marker of disease burden. She also earned a Master’s Degree in Clinical Research at UCSF. Dr. Mowry continued as a member of the faculty there before joining the Johns Hopkins Department of Neurology as an Assistant Professor in July, 2011; she received a joint appointment in Epidemiology in 2013. She was appointed as the inaugural Richard T. and Frances W. Johnson Professor in 2022. Over the past several years, Dr. Mowry has worked primarily to perform epidemiologic investigations of multiple sclerosis (MS) risk and prognostic factors and has evaluated both genetic and environmental contributors. While she has had a major role in several such studies, her most significant work led to the identification of the association of vitamin D status with relapse and brain lesion risk in patients with MS (Annals of Neurology 2010, Annals of Neurology 2012, European Journal of Neurology 2015). She also conducted the first pilot study comparing gut bacterial populations in patients with MS and healthy individuals (Journal of Investigative Medicine 2014). She was recently funded to investigate the impact of vitamin D supplementation on the metabolomics profile in patients with MS compared to healthy controls. She enjoys designing and conducting clinical trials in MS and is the Principal Investigator of the Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) multicenter vitamin D trial (NCT01490502), which is sponsored by the National MS Society and a smaller multicenter pilot study investigating vitamin D pharmacokinetics in MS patients and healthy controls (NCT01667796). She is also the recipient of a Harry Weaver Award from the National MS Society, in which she is investigating the impact of intermittent calorie restriction in MS. Finally, as Director of the MS Experimental Therapeutics Program at Johns Hopkins, she assists colleagues with study design and helps oversee the conduct of MS clinical trials. Dr. Mowry is rated as an Experienced provider by MediFind in the treatment of Optic Nerve Atrophy. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Optic Neuritis, and Neuromyelitis Optica. Dr. Mowry is board certified in American Board Of Psychiatry And Neurology.

Michael Carper, M.D. is an ophthalmologist in Baltimore, Maryland specializing in diplopia, optic neuropathy, multiple sclerosis and idiopathic intracranial hypertension. He has particular interest in stroke affecting visual function, idiopathic intracranial hypertension, and Leber Hereditary Optic Neuropathy. Dr. Carper completed his residency in neurology at West Virginia University. A native of North Carolina, he takes pleasure in his deep ties to the Mid-Atlantic and Appalachian regions and is privileged to serve the Baltimore area. Dr. Carper is an avid explorer and during his personal time enjoys trying new cuisines, or enjoying the outdoors on a hike or kayaking trip with his family. Dr. Carper is rated as an Experienced provider by MediFind in the treatment of Optic Nerve Atrophy. His clinical expertise encompasses Increased Intracranial Pressure, Oculomotor Apraxia Cogan Type, Papilledema, and Chemosis.

Dr. Pradeep Ramulu is a glaucoma specialist and the director of the Wilmer Eye Institute glaucoma division. He specializes in caring for both routine and complex glaucomas, including glaucomas requiring repeat operations, glaucoma occurring in the context of corneal or retinal disease and glaucoma occurring in newborns and young children. The Sheila K. West Professor of Ophthalmology at the Wilmer Eye Institute, Dr. Ramulu grew up in suburban Chicago, and became interested in the eye during medical school, during which time he studied the genes and proteins of the eye with Dr. Jeremy Nathans. After pursuing a residency in ophthalmology and fellowship training in glaucoma, he joined Wilmer in 2006. Dr. Ramulu is rated as an Experienced provider by MediFind in the treatment of Optic Nerve Atrophy. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Cataract, Iridectomy, and Cataract Removal. Dr. Ramulu is board certified in American Board Of Ophthalmology.

Michael X. Repka, M.D., M.B.A., is the David L. Guyton, M.D., and Feduniak Family Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in pediatric ophthalmology, strabismus, retinopathy of prematurity and pediatric neuro-ophthalmology. His clinical practice includes an interest in the management of strabismus and amblyopia. In these areas, he has a special interest in using alternatives to patching for the management of amblyopia and using strabismus surgery, botulinum toxin and adjustable sutures to treat strabismus. He also performs cataract surgery and intraocular lens implantation on children with cataracts and has a special interest in pediatric neuro-ophthalmology involving normal and abnormal visual development and the effect of injury and tumor on the visual system of the child. Dr. Repka received his M.D. degree from Thomas Jefferson University and completed his ophthalmology residency at Wills Eye Hospital. He completed fellowships in neuro-ophthalmology and pediatric ophthalmology at the Wilmer Eye Institute and joined the faculty in 1985. In addition to his clinical responsibilities, Dr. Repka is the vice chair for clinical practice at Wilmer. Dr. Repka is the past chairman of the Pediatric Eye Disease Investigator Group and past president of the Maryland Society of Eye Physicians and Surgeons. He is medical director of Government Affairs of the American Academy of Ophthalmology. Dr. Repka is rated as an Experienced provider by MediFind in the treatment of Optic Nerve Atrophy. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Strabismus, Brown Syndrome, Amblyopia, Cataract Removal, and Vitrectomy. Dr. Repka is board certified in American Board Of Ophthalmology.

Sezen Karakus, M.D., is an assistant professor of ophthalmology specializing in corneal and external eye diseases, with a particular focus on ocular surface conditions in patients with autoimmune and inflammatory disorders such as Sjögren's syndrome and ocular rosacea. Her expertise also extends to corneal diseases involving abnormal sensory nerves, such as neurotrophic keratitis and neuropathic corneal pain. She is skilled in performing routine and complex procedures, including cataract and intraocular lens surgeries, refractive surgeries, corneal transplants, ocular surface reconstructions and amniotic membrane transplantations. At the Wilmer Eye Institute, Johns Hopkins Medicine's Ocular Surface Diseases and Dry Eye Clinic, she plays an integral role as a team member, providing her clinical insights and expertise. Additionally, she serves as an ophthalmologist in the Postural Orthostatic Tachycardia Syndrome (POTS) program at Hopkins. This unique position allows her to address dysautonomia-related neuropathic eye pain and ocular surface diseases in patients with POTS, combining her eye specialization with a focus on this specific medical condition. As a clinician-scientist, her research revolves around ocular surface diseases. Dr. Karakus is actively investigating the role of the ocular surface microbiome in the pathogenesis of ocular rosacea. Her involvement in the NIH U24 Ocular Surface Microbiome Consortium allows her to collaborate with fellow experts in the field to standardize research methrods and develop validated protocols for studying the ocular surface microbiome. Another area of research interest for Dr. Karakus involves serological and tear biomarkers in Sjögren's disease. Through a longitudinal study, she aims to determine the utility of tissue-specific autoantibodies for early diagnosis of Sjögren's disease in patients with dry eyes. Understanding the broader impact of Sjögren's disease on the peripheral and central nervous systems is crucial, as it can manifest as severe ocular surface disease with diminished corneal sensation (neurotrophic keratitis) or intense eye pain without significant ocular surface disease (neuropathic corneal pain). Her clinical expertise and research contributions have earned Dr. Karakus recognition regionally and nationally, as evidenced by her role as a consultant in complex dry eye and ocular surface diseases. She takes pride in her dedication to advancing the understanding of ocular surface conditions and providing the best possible care for patients. By combining her specialization in corneal and external eye disease with her involvement in the POTS program and cutting-edge research on ocular surface diseases, Dr. Karakus strives to make a significant impact on patient care and contribute to the advancement of ophthalmology and related fields. Dr. Karakus is rated as an Experienced provider by MediFind in the treatment of Optic Nerve Atrophy. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Dry Eye Syndrome, Sjogren Syndrome, Cataract, Conjunctivitis (Pink Eye), and Corneal Transplant.

Robert Friedlaender is an Ophthalmologist practicing medicine in Silver Spring, Maryland. Dr. Friedlaender is rated as an Experienced provider by MediFind in the treatment of Optic Nerve Atrophy. His clinical expertise encompasses Optic Atrophy Type 1 and Optic Nerve Atrophy.

Dr. Rubin was one of 300 Ophthalmologists in the US selected to study a new steroid which was evaluated for use in asthma and allergy. In 2005 he was the Boucher Lecturer at USC Estelle Doheny Eye Center. Dr. Rubin has lectured at the NIH, the University of Illinois Eye and Ear Hospital and at the Jules Stein Eye Institute at UCLA. He was at the NIH for 15 years and has been involved in the care of patients with many eye disease and those related to receiving treatment for Melanoma, Bone Marrow/Stem Cell Transplant, Sickle Cell Disease, Cystanosis and NOMID. The latter two are very rare diseases, the treatments of which have resulted in remarkable benefit to the patients. Another interest has been in the treatment of severe dry eye. He was the recipient of the prestigious Richard C. Troutman Award in Ophthalmology at SUNY Downstate Medical College in April 2007. Dr. Rubin is a co-author in a number of prestigious journals, including the New England Journal of Medicine. Together with Dr. James Fielding Hejtmanick, he was involved in the discovery of the gene responsible for Francois Neetans Cornea Dystrophy. Dr. Rubin received a patent for a drug that inactivates Matrix Metallo Protease from the United States Patent and Trade Office. His research with this drug is ongoing and this may be a major contribution to the treatment of eye and medical diseases. He continues to collaborate with Dr. Hejmanick looking for the gene responsible for Pterygium, Fuch’s Dystrophy, Familial Macula Degeneration. He continues to collaborate with Manuel Datiles, MD at the National Eye Institute on Hypo-Alpha Protein cataracts, a cataract that affects men and women in their 50-60''s. His research continues to keep him involved in academics and abreast of the most recent discoveries in many fields of medicine. Dr. Rubin is rated as an Experienced provider by MediFind in the treatment of Optic Nerve Atrophy. His clinical expertise encompasses Glaucoma, Increased Intracranial Pressure, Optic Atrophy Type 1, and Optic Nerve Atrophy. Dr. Rubin is board certified in American Board Of Ophthalmology.